153 related articles for article (PubMed ID: 8884884)
1. Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism.
Piepponen TP; Ahtee L
Pharmacol Toxicol; 1995 Sep; 77(3):204-8. PubMed ID: 8884884
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
Borg PJ; Taylor DA
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
[TBL] [Abstract][Full Text] [Related]
3. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.
Piepponen TP; Honkanen A; Kivastik T; Zharkovsky A; Turtia A; Mikkola JA; Ahtee L
Pharmacol Biochem Behav; 1999 Jun; 63(2):245-52. PubMed ID: 10371653
[TBL] [Abstract][Full Text] [Related]
4. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
5. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Tokuyama S; Ho IK; Yamamoto T
Brain Res Bull; 2000 Jul; 52(5):363-9. PubMed ID: 10922515
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
7. Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice.
Narita M; Suzuki T; Funada M; Misawa M; Nagase H
Psychopharmacology (Berl); 1993; 111(4):423-6. PubMed ID: 7870983
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
Schad CA; Justice JB; Holtzman SG
J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460
[TBL] [Abstract][Full Text] [Related]
9. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
Honkanen A; Piepponen TP; Ahtee L
Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562
[TBL] [Abstract][Full Text] [Related]
10. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
[TBL] [Abstract][Full Text] [Related]
11. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effect of dihydroetorphine in diabetic mice.
Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
[TBL] [Abstract][Full Text] [Related]
13. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
Leventhal L; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.
Piepponen TP; Mikkola JA; Ruotsalainen M; Jonker D; Ahtee L
Br J Pharmacol; 1999 May; 127(1):268-74. PubMed ID: 10369482
[TBL] [Abstract][Full Text] [Related]
16. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
17. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
18. Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats.
Serra PA; Susini G; Rocchitta G; Migheli R; Dessanti G; Miele E; Desole MS; Miele M
Neurosci Lett; 2003 Jun; 344(1):9-12. PubMed ID: 12781909
[TBL] [Abstract][Full Text] [Related]
19. Effect of selective opiate antagonists on striatal acetylcholine and dopamine release.
Sandor NT; Lendvai B; Vizi ES
Brain Res Bull; 1992; 29(3-4):369-73. PubMed ID: 1327422
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
